French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

Prospective, Longitudinal and National Follow-up Program of Adult Patients With Somatotropic Hormone Deficiency for Whom Substituting Treatment by Norditropin SimpleXx Was Started

This study is conducted in Europe. The aim of this study is to extract data from the French National Registry holding information about patients having initiated growth hormone therapy with the objective to describe patients receiving growth hormone therapy, assess efficacy and safety of somatropin (Norditropin® SimpleXx®) and evaluate treatment compliance.

Inclusion Criteria:

• Adult with growth hormone deficiency
• Treated with Norditropin® SimpleXx (somatropin)